Lexicon Pharmaceuticals
LXRX
LXRX
126 hedge funds and large institutions have $940M invested in Lexicon Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $1.1B → $940M (-$162M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
66% less call options, than puts
Call options by funds: $450K | Put options by funds: $1.34M
Holders
126
Holding in Top 10
2
Calls
$450K
Puts
$1.34M
Top Buyers
| 1 | +$6.31M | |
| 2 | +$2.85M | |
| 3 | +$1.23M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.19M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$912K |
Top Sellers
| 1 | -$8.93M | |
| 2 | -$6.32M | |
| 3 | -$3.77M | |
| 4 |
Renaissance Technologies
New York
|
-$2.36M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.26M |